Rigel Pharmaceuticals
RIGL
#6655
Rank
HK$5.91 B
Marketcap
HK$314.25
Share price
-2.67%
Change (1 day)
-12.63%
Change (1 year)

EPS for Rigel Pharmaceuticals (RIGL)

EPS in 2026 (TTM): HK$137.57

According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$138.51. In 2025 the company made an earnings per share (EPS) of HK$158.65 an increase over its 2024 EPS that were of HK$7.76.

EPS history for Rigel Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$137.57-13.29%
2025HK$158.651944.44%
2024HK$7.76
2022-HK$26.65240%
2021-HK$7.84-37.5%
2020-HK$12.54-60%
2019-HK$31.35-11.11%
2018-HK$35.27-26.23%
2017-HK$47.82-17.57%
2016-HK$58.0125.42%
2015-HK$46.25-42.72%
2014-HK$80.74
2012-HK$104.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
HK$136.23-1.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$55.81-59.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-HK$2.98-102.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-HK$14.81-110.70%๐Ÿ‡บ๐Ÿ‡ธ USA